Oramed Pharmaceuticals
ORMP
#8622
Rank
A$0.15 B
Marketcap
$3.72
Share price
3.33%
Change (1 day)
-8.39%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): A$37.31 M

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings (TTM) are A$37.9 M. In 2023 the company made an earning of A$10.68 M an increase over its 2022 earnings that were of -A$54.94 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$37.31 M249.17%
2023 A$10.68 M-119.45%
2022 -A$54.94 M39.17%
2021 -A$39.48 M73.93%
2020 -A$22.7 M18.53%
2019 -A$19.15 M-16.62%
2018 -A$22.97 M38.32%
2017 -A$16.61 M12.51%
2016 -A$14.76 M25.01%
2015 -A$11.81 M18.18%
2014 -A$9.99 M39.72%
2013 -A$7.15 M46.4%
2012 -A$4.89 M128.32%
2011 -A$2.14 M-51.47%
2010 -A$4.41 M35.21%
2009 -A$3.26 M
2007 -A$5.13 M607.04%
2006 -A$0.73 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.79 B-2,157.69%๐Ÿ‡บ๐Ÿ‡ธ USA
A$25.27 B 66,581.97%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
A$10.12 B 26,606.34%๐Ÿ‡ซ๐Ÿ‡ท France
-A$0.77 M-102.01%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-A$0.31 B-899.66%๐Ÿ‡บ๐Ÿ‡ธ USA